Vaccines and Infectious Diseases

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

Go back to Resource Center

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

Authors:

Volume:

Pagination:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resource Center

Remdesivir for the Treatment of Covid-19 - Final Report

Go back to Resource Center

Remdesivir for the Treatment of Covid-19 - Final Report

Authors:

Volume:

Pagination:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resource Center

Non-Interventional Study Succeeds in Midst of Pandemic: Emmes Delivers High-Quality Data for Scientific Coverage

Read more about Non-Interventional Study Succeeds in Midst of Pandemic: Emmes Delivers High-Quality Data for Scientific Coverage

Vaccine Study Marked by Urgency and Complexity: Success Achieved with Experience, Flexibility and Dedication

Read more about Vaccine Study Marked by Urgency and Complexity: Success Achieved with Experience, Flexibility and Dedication

Vaccine clinical trials with RNA-Sequence endpoints to measure gene expression - Lessons Learned

Read more about Vaccine clinical trials with RNA-Sequence endpoints to measure gene expression - Lessons Learned

Accelerate your start-up plan for vaccines and infectious diseases with our CRO guidebook. Leverage this resource, to equip you to navigate the competitive landscape confidently to secure a reliable, long-term collaboration

Read more about Accelerate your start-up plan for vaccines and infectious diseases with our CRO guidebook. Leverage this resource, to equip you to navigate the competitive landscape confidently to secure a reliable, long-term collaboration

Informed consent process enhancement approaches for research participants who may be considered vulnerable populations

Go back to Resource Center

Informed consent process enhancement approaches for research participants who may be considered vulnerable populations

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resource Center

Challenges in implementing and managing clinical trials in developing countries: lessons learned by the national cancer institute's (NCI) AIDS malignancy consortium (AMC)

Go back to Resource Center

Challenges in implementing and managing clinical trials in developing countries: lessons learned by the national cancer institute's (NCI) AIDS malignancy consortium (AMC)

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resource Center

Developing a comprehensive site selection process for a cancer network in a resource-limited settings in sub-Saharan Africa

Go back to Resource Center

Developing a comprehensive site selection process for a cancer network in a resource-limited settings in sub-Saharan Africa

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resource Center

Transitioning to the remote collection of urine specimens for urine drug screening during COVID-19

Go back to Resource Center

Transitioning to the remote collection of urine specimens for urine drug screening during COVID-19

Authors:

Volume:

Pagination:

Issue:

Journal:

URL:

Keywords:

Abstract:

Go back to Resource Center

Subscribe to Vaccines and Infectious Diseases

Expertise Areas

Clinical Services

Emmes Story

Careers

Vaccines and Infectious Diseases

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

Remdesivir for the Treatment of Covid-19 - Final Report

Remdesivir for the Treatment of Covid-19 - Final Report

Non-Interventional Study Succeeds in Midst of Pandemic: Emmes Delivers High-Quality Data for Scientific Coverage

Vaccine Study Marked by Urgency and Complexity: Success Achieved with Experience, Flexibility and Dedication

Vaccine clinical trials with RNA-Sequence endpoints to measure gene expression - Lessons Learned

Accelerate your start-up plan for vaccines and infectious diseases with our CRO guidebook. Leverage this resource, to equip you to navigate the competitive landscape confidently to secure a reliable, long-term collaboration

Informed consent process enhancement approaches for research participants who may be considered vulnerable populations

Informed consent process enhancement approaches for research participants who may be considered vulnerable populations

Challenges in implementing and managing clinical trials in developing countries: lessons learned by the national cancer institute's (NCI) AIDS malignancy consortium (AMC)

Challenges in implementing and managing clinical trials in developing countries: lessons learned by the national cancer institute's (NCI) AIDS malignancy consortium (AMC)

Developing a comprehensive site selection process for a cancer network in a resource-limited settings in sub-Saharan Africa

Developing a comprehensive site selection process for a cancer network in a resource-limited settings in sub-Saharan Africa

Transitioning to the remote collection of urine specimens for urine drug screening during COVID-19

Transitioning to the remote collection of urine specimens for urine drug screening during COVID-19